Enveda Raises $311 Million in Series E Round
AI-driven natural-medicine biotech Enveda has raised $311 million in a Series E round, one of the larger late-stage biotech financings of the year.
Topic
AI Drug Discovery
Topic
AI Drug Discovery
Basecamp Research Lands $140m as AI Drug Design Draws Big Pharma Money
Basecamp Research closed an oversubscribed $140m Series C led by S32, with NVIDIA and Anthropic participating, as Roche opened a…
Nvidia-Backed Iambic Therapeutics Files for Nasdaq IPO
Iambic Therapeutics, which raised $461.8 million from Nvidia and others, filed Monday for a Nasdaq IPO under ticker IAM to fund t…
Investors Aim to Advance Basecamp Research Toward Clinical Trials
Investors are pushing Basecamp Research to move from protein and biodiversity data infrastructure toward human clinical trials, t…
Iambic Therapeutics Files for IPO as AI Drug Discovery Heats Up
AI drug discovery startup Iambic Therapeutics has filed for an initial public offering, Yahoo Finance reports, testing investor a…
Iambic Therapeutics Files for IPO
AI drug discovery startup Iambic Therapeutics has filed for an initial public offering, MarketScreener reports, joining the wave…
Generate Biomedicines Files Toward IPO as Flagship's AI Drug Startup Grows Up
Generate Biomedicines, the AI drug discovery startup built by Moderna backer Flagship Pioneering, is pitching an initial public o…
Enveda Doubles Valuation to $2B in $311M Series E Round
AI drug discovery startup Enveda raised $311M at a $2B valuation, double its worth from a year ago, to push nature-derived drug c…
AbbVie Signs On With Nvidia-Backed AI Drug Startup
AbbVie has partnered with a Nvidia-backed AI drug-discovery startup before its planned IPO, giving the company pharma validation…
Claude Found a CRISPR-Like Enzyme System in 21 Hours
Anthropic says Claude needed 21 hours and 950 agents to find a CRISPR-like enzyme system in bacteriophage DNA — with humans still…